Literature DB >> 30324723

Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents.

Christina L Szperka1, Juliana VanderPluym2, Serena L Orr3, Christopher B Oakley4, William Qubty5, Irene Patniyot6, Ana Marissa Lagman-Bartolome7, Cynthia Morris8, Jessica Gautreaux9, M Cristina Victorio10, Suzanne Hagler11, Sona Narula1, Meghan S Candee12, Catalina Cleves-Bayon13, Rashmi Rao9, Robert H Fryer14, Alma R Bicknese15, Marcy Yonker16, Andrew D Hershey3, Scott W Powers3, Peter J Goadsby5, Amy A Gelfand5.   

Abstract

Entities:  

Keywords:  adolescent; calcitonin gene-related peptide; migraine; monoclonal antibody; pediatric

Mesh：

Substances：

Year:  2018        PMID： 30324723      PMCID： PMC6258331          DOI： 10.1111/head.13414

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  120 in total

Review 1.  The placebo responder rate in children and adolescents.

Authors:  Donald W Lewis; Paul Winner; Warren Wasiewski
Journal:  Headache       Date:  2005-03       Impact factor: 5.887

2.  Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.

Authors: 
Journal:  Cephalalgia       Date:  2018-01       Impact factor: 6.292

Review 3.  First trimester exposure to topiramate and the risk of oral clefts in the offspring: A systematic review and meta-analysis.

Authors:  Abdulaziz M S Alsaad; Shahnaz Akthar Chaudhry; Gideon Koren
Journal:  Reprod Toxicol       Date:  2015-03-20       Impact factor: 3.143

4.  Calcitonin gene-related peptide (CALCA) is a proangiogenic growth factor in the human placental development.

Authors:  Yuan-Lin Dong; Deepti M Reddy; Kortney E Green; Madhu S Chauhan; Hui-Qun Wang; Manubai Nagamani; Gary D V Hankins; Chandra Yallampalli
Journal:  Biol Reprod       Date:  2007-01-31       Impact factor: 4.285

5.  Access to care for children of the working poor.

Authors:  S Guendelman; M Pearl
Journal:  Arch Pediatr Adolesc Med       Date:  2001-06

6.  Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine.

Authors:  Scott W Powers; Christopher S Coffey; Leigh A Chamberlin; Dixie J Ecklund; Elizabeth A Klingner; Jon W Yankey; Leslie L Korbee; Linda L Porter; Andrew D Hershey
Journal:  N Engl J Med       Date:  2016-10-27       Impact factor: 91.245

7.  Calcitonin gene-related peptide in human obesity.

Authors:  P M Zelissen; H P Koppeschaar; C J Lips; W H Hackeng
Journal:  Peptides       Date:  1991 Jul-Aug       Impact factor: 3.750

8.  The Childhood and Adolescent Migraine Prevention (CHAMP) Study: A Report on Baseline Characteristics of Participants.

Authors:  Scott W Powers; Andrew D Hershey; Christopher S Coffey; Leigh A Chamberlin; Dixie J D Ecklund; Stephanie M Sullivan; Elizabeth A Klingner; Jon W Yankey; Susmita Kashikar-Zuck; Leslie L Korbee; Michele L Costigan; Holly H Riss; Linda L Porter
Journal:  Headache       Date:  2016-04-04       Impact factor: 5.887

9.  Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine.

Authors:  Frederick J Derosier; Donald Lewis; Andrew D Hershey; Paul K Winner; Eric Pearlman; Arnold David Rothner; Steven L Linder; David K Goodman; Theresa B Jimenez; Wendy K Granberry; M Chris Runken
Journal:  Pediatrics       Date:  2012-05-14       Impact factor: 7.124

Review 10.  The role of peripheral nerve fibers and their neurotransmitters in cartilage and bone physiology and pathophysiology.

Authors:  Susanne G Grässel
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156
View more
  12 in total

Review 1.  Cardiovascular Disease and Migraine: Are the New Treatments Safe?

Authors:  Jennifer Robblee; Lauren K Harvey
Journal:  Curr Pain Headache Rep       Date:  2022-06-25

Review 2.  The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine.

Authors:  Fred Cohen; Hsiangkuo Yuan; E M G DePoy; Stephen D Silberstein
Journal:  Neurotherapeutics       Date:  2022-04-14       Impact factor: 6.088

Review 3.  Genetic and epigenetic mechanisms influencing acute to chronic postsurgical pain transitions in pediatrics: Preclinical to clinical evidence.

Authors:  Adam J Dourson; Adam Willits; Namrata G R Raut; Leena Kader; Erin Young; Michael P Jankowski; Vidya Chidambaran
Journal:  Can J Pain       Date:  2022-05-10

4.  Calcitonin Gene-Related Peptide Monoclonal Antibody Use for the Preventive Treatment of Refractory Headache Disorders in Adolescents.

Authors:  Kaitlin A Greene; Carlyn P Gentile; Christina L Szperka; Marcy Yonker; Amy A Gelfand; Barbara Grimes; Samantha L Irwin
Journal:  Pediatr Neurol       Date:  2020-10-05       Impact factor: 3.372

Review 5.  CGRP in Childhood and Adolescence Migraine: (Patho)physiological and Clinical Aspects.

Authors:  Stefan Evers
Journal:  Curr Pain Headache Rep       Date:  2022-03-30

Review 6.  Role of Atogepant in the Treatment of Episodic Migraines: Clinical Perspectives and Considerations.

Authors:  Fred Cohen; Hsiangkuo Yuan
Journal:  Ther Clin Risk Manag       Date:  2022-04-22       Impact factor: 2.755

Review 7.  Emerging Pharmacological Treatments for Migraine in the Pediatric Population.

Authors:  Luigi Francesco Iannone; Francesco De Cesaris; Pierangelo Geppetti
Journal:  Life (Basel)       Date:  2022-04-05

Review 8.  Headache in Children and Adolescents.

Authors:  Christina Szperka
Journal:  Continuum (Minneap Minn)       Date:  2021-06-01

9.  Differential Diagnosis of Cyclic Vomiting and Periodic Headaches in a Child with Ventriculoperitoneal Shunt: Case Report of Chronic Shunt Overdrainage.

Authors:  Maximilian David Mauritz; Carola Hasan; Lutz Schreiber; Andreas Wegener-Panzer; Sylvia Barth; Boris Zernikow
Journal:  Children (Basel)       Date:  2022-03-18

Review 10.  Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor.

Authors:  Andrew Blumenfeld; Paul L Durham; Alexander Feoktistov; Debbie L Hay; Andrew F Russo; Ira Turner
Journal:  Neurol Ther       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.